RxPros is reshaping the direct-to-consumer wellness market by offering compounded semaglutide starting at $89.97 per month and compounded tirzepatide at $119.97 per month. Operating as a LegitScript-certified telemedicine provider, the platform eliminates membership fees and dose-escalation price hikes, earning a 4.7-star rating across more than 19,000 verified Trustpilot reviews.
There is an unwritten rule in the weight loss medication world that patients can either have an affordable price or a company they actually trust, but never both. The expensive clinical programs justify their steep monthly invoices with buzzwords like “concierge,” while discount options routinely cut corners on clinical support.
The Cost Breakdown That Defies Industry Norms
On paper, market-low pricing is usually a massive red flag in telehealth. Most major GLP-1 providers advertise entry-level semaglutide programs between $150 and $300 per month, while tirzepatide frequently lands anywhere from $180 to $500. Those baseline figures rarely tell the whole story, as many platforms layer on mandatory membership fees, separate provider visit charges, and dose-based price escalation.
RxPros bypasses those extra charges entirely by keeping its financial structure remarkably flat. Compounded semaglutide sits at $89.97 per month, and compounded tirzepatide is priced at $119.97 per month. These all-inclusive figures cover the initial prescription, the medication itself, doctor consultations, and ongoing clinical check-ins. More importantly, the monthly rate remains locked even as a patient’s dosage titrates upward over time.
The Bottom Line
- Flat Pricing: Monthly rates start at $89.97 for semaglutide and $119.97 for tirzepatide with zero hidden membership fees.
- Verified Scale: The provider maintains an “Excellent” 4.7-star rating across over 19,000 Trustpilot reviews with an all-invited feedback policy.
- Clinical Standards: Operations are backed by LegitScript certification, ensuring prescription-only oversight by licensed U.S. medical providers.
Decoding the Trustpilot Metrics and Volume
Skepticism surrounding low-cost healthcare models is entirely justified, making independent verification essential. RxPros holds an official “Excellent” Trustpilot designation backed by more than 19,000 reviews. Crucially, Trustpilot publicly classifies the platform as a company that invites its entire customer base to leave reviews rather than selectively curating positive feedback.
That all-invited approach ensures the 4.7-star average reflects real consumer experiences at a scale difficult to manipulate. Patient testimonials consistently highlight rapid approval windows, cold-insulated overnight shipping, and responsive customer service teams. Many reviewers explicitly note transitioning away from larger telehealth competitors whose pricing structures ballooned mid-treatment.
Clinical Guardrails and Regulatory Compliance
Low pricing models often invite questions regarding medical oversight. RxPros operates as a LegitScript-certified telemedicine platform, an independent credentialing standard that evaluates online healthcare providers and pharmacies for strict regulatory compliance. The treatment path remains strictly prescription-only from start to finish.
Patients must complete a comprehensive online health assessment evaluated by a licensed U.S. medical provider to determine if GLP-1 therapy is clinically appropriate. Approved prescriptions are then dispensed by licensed U.S. pharmacies. Ongoing medical support, including dose adjustments and provider check-ins, remains integrated into the core service package at no additional cost.
Inside the Telehealth Margin Structure
The wider wellness economy has long relied on bloated marketing budgets and complex subscription tiers to sustain high valuations. By trimming excess marketing spend and eliminating aggressive dose-based price hikes, streamlined providers can pass operational savings directly to the consumer.
As consumer habits shift toward transparent pricing in digital health, platforms that rely on hidden fees face mounting pressure to adapt. Whether legacy telehealth providers will match these flat-rate models remains one of the most pressing questions in digital therapeutics today. What are your thoughts on how transparent pricing is changing the telehealth landscape? Let us know in the comments below.
